Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06535945
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HALT
Brief Summary:
To verify whether albumin administration to achieve serum concentration above 30gL treated group and its maintenance within plasmatic physiologic range 30 gL for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration when serum concentration is at 20 gL or below control
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None